Zimmer Biomet beats the Street in Q1, maintains full-year guidance
Zimmer Biomet's first-quarter results exceeded Wall Street's expectations, but the company offered no improvement in its full-year outlook.
Stay updated with breaking news from Ivan Tornos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zimmer Biomet's first-quarter results exceeded Wall Street's expectations, but the company offered no improvement in its full-year outlook.
Print-link Zimmer Biomet Announces Successful Completion of World's First Robotic-Assisted Shoulder Replacement Surgery with ROSA® Shoulder System Zimmer Biomet...
These 10 defensive stocks supply investors with reliable earnings, and often dividends, when markets look uncertain.
Zimmer Biomet's new CEO, Ivan Tornos, earned $10.2 million in total compensation in 2023, according to a recent Securities and Exchange Commission proxy filing.
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...